EPO Patent EP4098656A1: Peptide Inhibiting Snare Complex Formation

The European Patent Office has published patent application EP4098656A1, titled 'Peptide Inhibiting Formation of Snare Complex and Use Thereof', filed by Medytox Inc. The patent application details a peptide designed to inhibit snare complex formation and its potential applications.

EPO Patent Publication: Anti-VEGF Antibody Constructs for Vestibular Schwannoma

The European Patent Office has published a new patent application, EP4255570A1, related to anti-VEGF antibody constructs and methods for treating vestibular schwannoma. The application was filed by Akouos, Inc. and published on March 11, 2026.

EPO Patent Bulletin: Therapeutic Peptides from Frzb Protein Netrin-Like Domain

The European Patent Office has published patent application EP4153611A1 concerning therapeutic peptides derived from the netrin-like domain of the Frzb protein. The publication details potential therapeutic applications and lists the applicants and inventors.

EPO Patent Publication EP4125376A1: Antimicrobial Peptides

The European Patent Office published patent application EP4125376A1 on March 11, 2026, concerning antimicrobial peptides developed by Materias S.r.l. This publication details specific peptide sequences and their potential applications.

EPO Patent EP4204092A1: Multi-specific Antigen Binding Molecules Targeting HIV

The European Patent Office has published patent application EP4204092A1, filed by Gilead Sciences, Inc., concerning multi-specific antigen binding molecules targeting HIV. The patent details methods of use for these molecules in treating or preventing HIV infections.

EPO Patent EP4188944A1: Biostimulant Peptides for Agriculture

The European Patent Office has published patent application EP4188944A1 concerning biostimulant and bioprotective peptides for use in agriculture. The patent was filed by Materias S.r.l. and published on March 11, 2026.

EPO Patent EP3915587A1: Improved Cell-Targeting Binding Molecule

The European Patent Office has published patent application EP3915587A1 for an "Improved Cell-Targeting Binding Molecule" filed by Sapreme Technologies B.V. The patent publication date is March 11, 2026, and it covers applications in various European designated states.

Human Anti-Human CD22 CAR Patent Application EP4130040A1

The European Patent Office has published patent application EP4130040A1 concerning a fully human anti-human CD22 chimeric antigen receptor and its application, filed by Nanjing Iaso Biotechnology Co., Ltd. The publication date is March 11, 2026.

EPO Patent Bulletin - Chimeric Antigen Receptor-Modified NK-92 Cells

The European Patent Office (EPO) published patent application EP4097219A1 concerning chimeric antigen receptor-modified NK-92 cells targeting EGFR super-family receptors. The application was filed by ImmunityBio, Inc. and lists Hermes J. Garban et al. as inventors. The publication date is March 11, 2026.

Immunocytokines and Uses Thereof Patent EP4263836A1

The European Patent Office has published patent application EP4263836A1 concerning immunocytokines and their uses, filed by Immunowake Inc. The publication date is March 11, 2026. This patent application relates to advancements in biotechnology and pharmaceutical applications.